Michael Abbott - Mar 27, 2023 Form 4 Insider Report for Columbia Care Inc. (CCHWF)

Role
Chairman, Director
Signature
/s/ David Sirolly as attorney-in-fact for Michael Abbott
Stock symbol
CCHWF
Transactions as of
Mar 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 09:28 PM
Previous filing
Dec 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCHWF Common Shares Options Exercise +469K +61.55% 1.23M Mar 27, 2023 Direct F1, F2
transaction CCHWF Common Shares Options Exercise +320K +25.98% 1.55M Mar 27, 2023 Direct F1, F3
transaction CCHWF Common Shares Options Exercise +169K +10.91% 1.72M Mar 27, 2023 Direct F1, F4
transaction CCHWF Common Shares Options Exercise +51.2K +2.98% 1.77M Mar 27, 2023 Direct F1, F5
transaction CCHWF Common Shares Options Exercise +633K +35.77% 2.4M Mar 27, 2023 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCHWF Restricted Stock Units Options Exercise $0 -469K -100% $0.00* 0 Mar 27, 2023 Common Shares 469K Direct F1, F2
transaction CCHWF Restricted Stock Units Options Exercise $0 -320K -100% $0.00* 0 Mar 27, 2023 Common Shares 320K Direct F1, F3
transaction CCHWF Restricted Stock Units Options Exercise $0 -169K -100% $0.00* 0 Mar 27, 2023 Common Shares 169K Direct F1, F4
transaction CCHWF Restricted Stock Units Options Exercise $0 -51.2K -100% $0.00* 0 Mar 27, 2023 Common Shares 51.2K Direct F1, F5
transaction CCHWF Restricted Stock Units Options Exercise $0 -633K -100% $0.00* 0 Mar 27, 2023 Common Shares 633K Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs were granted on March 31, 2022, and vested 1/4 annually beginning March 31, 2023, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated as a result of a termination and release of claims agreement between the Issuer and the reporting person dated March 15, 2023 (the"Agreement").
F3 The RSUs were granted on March 23, 2021, and vested 1/4 annually beginning March 23, 2022, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F4 The RSUs were granted on March 31, 2020, and vested 1/4 annually beginning March 31, 2021, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F5 The RSUs were granted on September 30, 2019, and vested 1/4 annually beginning April 29, 2020, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F6 The performance stock units ("PSUs") were granted on March 31, 2020, and March 23, 2021. Each PSU represents a contingent right to receive one share of the Issuer's common stock. Vesting was accelerated pursuant to the Agreement.